Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sponsor-FDA Communications In IND Phase Will Get Outside Review

Aug 15 2018

• By Derrick Gingery

FDA entrance sign 2016

Related Content

US FDA's Benefit/Risk Framework Gets High Marks But Could Be Improved

Sep 20 2017

Benefit-Risk Frameworks May Be Coming To US FDA Advisory Committees

Apr 03 2018

Decline In Civil Discourse Harms US FDA's Operations, Woodcock Says

Jun 29 2018

PDUFA V ‘Program’ Gets Positive Evaluation – Except For Inspections

Apr 02 2015

PDUFA V Reviews Are ‘Best Ever’ For Some Sponsors, Maybe Not FDA

Apr 06 2015

PDUFA V 'Program' First-Cycle Approval Rates Significantly Higher For All Applications

Dec 13 2016

Additional Topics

United States FDA Regulation Drug Review BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window